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MaAtrial fibrillation (AF) and stroke are important major health problems that share common risk factors and frequently
coexist. Left atrial (LA) remodeling is an important underlying substrate for AF and stroke. LA dilation and dysfunction
form a prothrombotic milieu characterized by blood stasis and endothelial dysfunction. In addition, alterations of the
atrial cardiomyocytes, increase of noncollagen deposits in the interstitial space and fibrosis, favor the occurrence of
re-entry that predisposes to AF. Eventually, AF further impairs LA function and promotes LA remodeling, closing
a self-perpetuating vicious circle. Multimodality imaging provides a comprehensive evaluation of several aspects
of LA remodeling and offers several parameters to identify patients at risk of AF and stroke. How multimodality
imaging can be integrated in clinical management of patients at risk of AF and stroke is the focus of the present
review paper. (J Am Coll Cardiol 2017;70:3157–72) © 2017 by the American College of Cardiology Foundation.A trial fibrillation (AF) and stroke are highlyprevalent conditions that share commonrisk factors and frequently coexist (1). The
presence of AF is independently associated with
5-fold increased risk of stroke (2,3). Left atrial (LA)
remodeling is an important underlying substrate for
AF and stroke. Data from a population-based cohort
showed that LA dilation provided good accuracy to
identify the individuals that will present with AFm the aDepartment of Cardiology, Leiden University Medical Center, Leid
Cardiac Electrophysiology, Montefiore Medical Center, Albert Einstein Col
Cardiology, Liverpool Hospital, University of New South Wales, Sydney, N
dicine, Division of Cardiovascular Medicine, University of Oxford, Oxford
ction of Cardiac Electrophysiology, University of Utah Health Sciences C
logy of the Leiden University Medical Center has received unrestricted
entific, and Edwards Lifesciences. Dr. Delgado has received speaker fees f
reoataxis, Biosense Webster, and St. Jude Medical; and has received hon
entific, EpiEP, Pfizer, and Janssen. Dr. Leung has received grants from Pfiz
sed biomarkers by Roche Diagnostics at no cost to the investigators. Dr. Ma
rdiac Design, Medtronic, Preventice, Vytronus, Biosense Webster, Marrek,
m Abbott, Boston Scientific, GE Healthcare, Siemens, Biotronik, Bytronus,
rrek and Cardiac Design. All other authors have reported that they have n
disclose.
nuscript received October 1, 2017; accepted October 22, 2017.(area under the curve 0.86) (4). In addition, a recent
systematic review including 67,875 participants in
sinus rhythm demonstrated that the risk of stroke
increases along with the LA size (5). Age, obesity,
diabetes mellitus, hypertension, and sleep apnea
cause LA dilation and dysfunction, creating a
prothrombotic milieu characterized by blood stasis
and endothelial dysfunction. This type of atrial
cardiomyopathy has been suggested as a cause ofen, the Netherlands; bDivision of Cardiology, Section
lege of Medicine, New York, New York; cDepartment
ew South Wales, Australia; dRadcliffe Department of
, United Kingdom; and the eDivision of Cardiology,
enter, Salt Lake City, Utah. The Department of Car-
research grants from Medtronic, Biotronik, Boston
rom Abbott Vascular. Dr. Di Biase is a consultant for
oraria/travel fees from Medtronic, Biotronik, Boston
er. Dr. Casadei has received measurements of blood-
rrouche has been a consultant for Abbott, Biotronik,
and Boston Scientific; has received research funding
and Biosense Webster; and has company interest in
o relationships relevant to the contents of this paper




AF = atrial fibrillation
CMR = cardiovascular magnetic
resonance
CT = computed tomography
IQR = interquartile range
LA = left atrial/atrium
LAA = left atrial appendage
LGE = late gadolinium
enhancement
LV = left ventricle/ventricular
PA-TDI = P-wave to peak
A’-wave on tissue Doppler
imaging
TDI = tissue Doppler imaging
TEE = transesophageal
echocardiography
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3158thromboembolism before AF occurs. In
addition, LA remodeling is accompanied
by alterations of the atrial cardiomyocytes,
increase of noncollagen deposits in the inter-
stitial space, and fibrosis that favor the occur-
rence of re-entry that predisposes to AF.
AF subsequently further impairs LA function
and promotes LA remodeling.
Currently, risk stratification of AF patients
for the occurrence of stroke is based on
clinical scores that do not include LA
remodeling and function in their algorithms.
By contrast, novel therapeutic options such
as radiofrequency catheter ablation tech-
niques and transcatheter closure of the left
atrial appendage (LAA) demand advanced
imaging to maximize patient safety and
procedural outcomes. Multimodality imaging
provides a comprehensive evaluation of
several aspects of LA remodeling and offers
several parameters to identify patients at riskof AF and stroke. The present review paper summa-
rizes the role of multimodality imaging to assess the
pathophysiology of AF and stroke, and highlights the
key parameters to answer specific clinical questions.
1) What are the LA and LAA remodeling characteris-
tics associated with AF and stroke? 2) How can im-
aging help to identify the patients who will
benefit from invasive therapies (AF ablation and LAA
closure)?
LA: NORMAL ANATOMY AND FUNCTION
Because LA structural remodeling and AF are closely
related, it is recommended that LA size and anatomy
be assessed routinely in all AF patients (6). LA size is
typically assessed with standard 2-dimensional (2D)
echocardiography. The LA anteroposterior diameter
derived from a conventional parasternal long-axis
view is used to estimate LA size. However, because
asymmetrical remodeling occurs in LA dilation, it is
recommended that LA volumes be assessed using a
volumetric method, such as the modified Simpson
biplane method of discs (Figure 1). With the use of
3-dimensional (3D) imaging modalities, LA volumes
can be assessed even more accurately. Real-time 3D
echocardiographic measurements of LA volumes have
been validated against computed tomography (CT)
and cardiovascular magnetic resonance (CMR), and
the technique has improved diagnostic accuracy and
reproducibility compared with 2D echocardiography
(Figure 1). Normal reference values for 3D LA volume
are 15 to 42 ml/m2 in men and 15 to 39 ml/m2 in
women (7). Furthermore, assessment of pulmonaryvein anatomy is relevant when an ablation procedure
is considered in AF patients. It has been demon-
strated that pulmonary vein anatomy is highly
variable. Variations in the number and location of the
pulmonary veins are associated with outcome in
catheter ablation procedures for AF (8). Typically,
CT or CMR is performed before the ablation procedure
to assess pulmonary vein anatomy. The 3D recon-
structed images provide detailed information on LA
and pulmonary vein anatomy that can be used to
guide the ablation procedure.
In addition to the anatomic information of the LA,
assessment of LA function is important because it
contributes 30% of the left ventricular (LV) stroke
volume. Impaired LA function has been associated
with increased risk of stroke and AF (5,9). Normal LA
function can be divided into 3 distinct phases. During
ventricular systole, the LA serves as a reservoir for
blood drained by the pulmonary veins. During early
ventricular diastole, the LA is a conduit for the
pulmonary venous return. During late systole,
the booster pump function of the LA completes the
LV filling. Whereas the LA reservoir function is
determined by atrial compliance, atrial relaxation,
and contractility, as well as LV systolic function and
end-systolic volume, the LA conduit function is
influenced by LA compliance and LV relaxation and
compliance, and the LA booster pump function
is influenced by venous return, LV end-diastolic
pressures, and systolic reserve. These 3 functions
can be assessed with echocardiographic and CMR
techniques. How anatomic and functional assessment
of the LA permits stratification of patients with AF is
discussed in the next sections.
LA REMODELING: SUBSTRATE FOR AF
LA dilation and myocardial fibrosis causing LA
dysfunction and electromechanical conduction delay
characterize LA remodeling and form the substrate
for AF. In recent years, there has been a resurgence of
interest in imaging the LA to better understand the LA
structural and functional changes associated with
new-onset and perpetuation of AF. LA volumes
preferably assessed with 3D imaging techniques are
frequently considered in the therapeutic decision
making of AF patients. LA volume has been shown
to be a stronger determinant of success of radio-
frequency catheter ablation techniques than the type
of AF (i.e., paroxysmal vs. persistent) (10).
Late gadolinium contrast enhanced (LGE) CMR has
significantly improved our understanding of atrial
fibrosis as the hallmark of structural LA remodeling in
AF. Gadolinium contrast media accumulate in the
FIGURE 1 LA Volume Assessment Using 2D and 3D Echocardiography
(A and B) The 2-dimensional (2D) echocardiographic measurement of left atrial (LA) volume using the Simpson biplane approach in the apical
4-chamber (A) and 2-chamber (B) views are shown. The LA appendage is not included in the tracing of the endocardial border. (C) Real-time
3-dimensional (3D) echocardiographic measurement of LA volumes is shown. LA volumes may be obtained with improved anatomic alignment,
by tracing the blood tissue interface on 3D-guided triplane images in the apical 4-, 2-, and 3-chamber views (C). Live-3D (D) and full-volume
multibeat reconstructions (E) may also be used to measure LA volumes at any phase of the cardiac cycle, providing improved alignment at
the geometric center of the left atrium.
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3159extracellular space and appear as bright white areas
in the atrial myocardium. A dynamic threshold
algorithm identifies the regions of fibrosis as areas
with thresholds 2 to 4 SD higher than the threshold
defining normal LA myocardial tissue (11). On the
basis of the extent of LA LGE, a classification of LA
fibrosis has been proposed ranging from stage 1,
when the fibrosis extension is <10% of the LA wall, to
stage 4 when the extension of fibrosis is $30%
(Figure 2) (12). The presence of interstitial fibrosis in
the subepicardial myocardium favors electrical
dissociation and leads to wave breaks and rotors
that characterize AF (13,14). LA fibrosis extent has
been shown to significantly impact on the efficacy
of radiofrequency catheter ablation techniques
for AF (12). The DECAAF (Delayed-Enhancement
Magnetic Resonance Imaging Determinant of
Successful Radiofrequency Catheter Ablation of Atrial
Fibrillation) study provides evidence that thepre-ablation fibrosis burden should be taken into
consideration when selecting patients for catheter
ablation (12). Each 1% increase in LA fibrosis was
independently associated with 6% increased risk
of arrhythmia recurrence at follow-up. Patients
with <20% LA fibrosis (stages 1 and 2) had the lower
hazards of presenting with arrhythmia recurrence
after catheter ablation (Figure 2).
Assessment of LA function provides further
insights in the consequences of LA structural
remodeling. The association between LA reservoir
function and AF has been shown in 574 adults
without arrhythmia followed up for a mean of 1.9 
1.2 years (15). The age-adjusted risk of AF or atrial
flutter was highest for subjects with both reduced LA
reservoir function (<49%) and increased maximum
LA volume (>38 ml/m2). Advanced echocardiographic
techniques such as pulsed-wave or color-coded tissue
Doppler imaging (TDI) enable assessment of the peak
FIGURE 2 Assessment of LA Fibrosis With LGE CMR in AF and Implications for the Efficacy of Invasive Therapies

















Stage 1 (<10% of LA wall)
Posterior view Anterior view
Posterior view
Fibrotic tissueHealthy
Anterior view Posterior view Anterior view
Posterior view Anterior view
Stage 3 (≥20% -<30% of LA wall)
Stage 2 (≥10% -<20% of LA wall)
Stage 4 (≥30% of LA wall)
(A) The various stages of left atrial (LA) fibrosis obtained from late gadolinium contrast enhanced (LGE) cardiac magnetic resonance (CMR).
The healthy LA myocardium is coded in blue, whereas the fibrous tissue is coded in shades of green. The cubic spline analysis (B) shows the
association between the LA fibrosis extent and the hazard ratio of arrhythmia recurrence after invasive treatment of atrial fibrillation (AF).
The analysis is adjusted for age, sex, hypertension, congestive heart failure, mitral valve disease, diabetes, AF type, LA volume,
left ventricular ejection fraction, and participating center. Reproduced with permission from Marrouche et al. (12).
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3160velocity at the mitral annulus in late diastole due to
atrial contraction (A0) (Figure 3). In patients with
chronic AF cardioverted to sinus rhythm, low
segmental atrial velocities have been demonstrated
immediately post-cardioversion followed by a tem-
poral increase in segmental atrial contractility up to
6 months later (16). In addition, strain and strain rate
imaging examine the magnitude and the rate of
myocardial deformation during the cardiac cycle and
may be assessed using either color-coded TDI or 2D
speckle tracking or vector velocity imaging (Figure 3).A reduced LA reservoir strain has been shown to
correlate with LA wall fibrosis on CMR in patients
with AF (11). In patients undergoing catheter ablation
for AF, LA reservoir function is predictive of main-
taining sinus rhythm (17), and is an independent
predictor of LA reverse remodeling (18).
The LA remodeling process has been also associ-
ated with electrical remodeling with areas of slow
conduction, shortening of the atrial refractoriness,
and increased nonuniform anisotropy that lead to re-
entrant circuits and AF. Surface electrocardiograms,
FIGURE 3 LA Function Assessment Using Strain Measured by 2D Speckle Tracking Echocardiography and Color-Coded TDI Velocities
(A and C) The peak positive longitudinal strain (εs), corresponding to atrial reservoir function, the strain during early and late diastole (εe and
εa, respectively) corresponding to the conduit and booster pump function, with left ventricular end-diastole (QRS onset) as the reference
point are shown. The atrial color-coded tissue Doppler imaging (TDI) velocity trace obtained with the sample volume placed in the basal lateral
atrial wall is shown in B and D. The trace represents the atrial velocities measured in this region throughout the cardiac cycle. The S0 is
positive and occurs in ventricular systole; the E0 and A0 are negative deflections and occur in early and late ventricular diastole, respectively.
A shows a normal subject with preserved peak left atrial (LA) strain of 60%. This same patient has a normal E0 velocity of 14 cm/s (B).
C displays a patient with history of paroxysmal atrial fibrillation and reduced peak LA strain of 21%, and E0 velocity of 8 cm/s (D).
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3161conventional endocardial electrograms, or 3D
electroanatomic mapping systems characterize the
electrical remodeling. Color-coded TDI echocardiog-
raphy by way of P-wave to peak A0-wave on
TDI (PA-TDI), provides a noninvasive parameter
reflecting the electromechanical delay, likely reflect-
ing fibrosis formation in the LA (Figure 4). More
specifically, PA-TDI is the time delay between the
electrical LA activation (indicated by the P-wave on
the surface electrocardiogram) and the mechanical
atrial contraction (reflected by the peak A0-wave on
TDI). The value of PA-TDI to predict new-onset AF
was evaluated in 249 patients without previous
AF (19). Patients who presented with AF (n ¼ 15, 6%)
during follow-up had longer PA-TDI duration than
patients who remained in sinus rhythm (172  25 ms
vs. 150  20 ms; p ¼ 0.001). Prolonged PA-TDI
was independently associated with new-onset AF
(odds ratio: 1.37; p ¼ 0.027). This parameter has
also been correlated with the efficacy of radio-
frequency catheter ablation: patients with longerPA-TDI had higher risk of AF recurrences at follow-up
(odds ratio: 1.04; p < 0.001) (20).
Finally, imaging of the adipose tissue that accu-
mulates around the LA provides additional insights in
the pathophysiology of AF. Fatty tissue infiltrating
the atrial subepicardium is universally observed (13).
However, in patients with AF, the fatty tissue shows
characteristic structural remodeling with adipocytes
intermingling with fibrous bundles, myocytes, and
thick and irregular epicardium. The extent of fibrosis
within this fatty infiltration is significantly larger
among patients with persistent AF (64  23%) as
compared with paroxysmal AF and sinus rhythm
patients (50  21% vs. 37  24%, respectively;
p ¼ 0.0004) (13). Studies using CT have correlated the
extent of adipose LA tissue with the presence of AF
(21–23). In a recent study including 400 patients
evaluated with CT, each gram increase of posterior LA
adipose tissue was associated with 1.32 odds ratio
of having AF (95% confidence interval: 1.22 to 1.43;
p < 0.001) (23).
FIGURE 4 Measurement of the Time Delay Between Electrical and Mechanical Activation of the LA (PA-TDI) and Its Association With AF
Ablation Efficacy
From the onset of the electrical activation of the left atrium (P-wave on surface electrocardiogram [red line]), the time to peak myocardial
velocity of the LA contraction is measured (P-wave to peak A’-wave on tissue Doppler imaging [PA-TDI]). In A, the patient had a PA-TDI of
120 ms and remained in sinus rhythm after AF ablation. By contrast, the patient presented in B had longer PA-TDI (180 ms) and presented with
recurrence of AF after ablation. Abbreviations as in Figures 1 to 3.
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4D ¼ 4-dimensional; CMR ¼ cardiac magnetic resonance; LA ¼ left atrium;
LAA ¼ left atrial appendage; LGE ¼ late gadolinium enhancement.
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3162LA AND RISK FOR STROKE
Cardioembolic stroke secondary to AF accounts for
15% of all ischemic strokes (24). Current risk scoring
systems to estimate the risk of stroke in patients
with AF and to identify those who will benefit from
anticoagulation therapy are primarily based on
demographic and clinical characteristics. However,
the accuracy of these risk score systems to predict
ischemic stroke in AF patients is modest, which
may lead to overuse of anticoagulation in low-risk
patients (25,26).
Several cardiac imaging-based variables have been
associated with increased risk of stroke in AF patients
(Table 1) (27). However, it remains unclear whether
the addition of those variables to current risk scoring
systems would lead to superior stroke risk stratifica-
tion. The LA remodeling process associated with
AF forms a milieu that enhances the risk of blood
stagnation and thrombus formation. Several studies
have shown that increased LA dimensions, presence
of spontaneous echo contrast (sludge), and LAA
thrombus and LAA flow peak velocity <20 cm/s
measured on echocardiography, and LAA non-
chicken wing morphology as assessed on multi-
detector row CT and CMR are associated with
increased risk of stroke in AF patients (28–30). In
addition, LA reservoir function measured with 2Dspeckle tracking longitudinal strain echocardiography
has also been associated with increased risk of stroke
(9). In a case-control study, Leong et al. (9) showed
that LA reservoir function was significantly lower in
patients with stroke as compared with controls (30 
7.3% vs. 34  6.7%; p < 0.001). Each 1% reduction in
LA reservoir function was associated with 7% increase
in the risk of stroke (p < 0.001). Using tissue-tracking
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3163CMR, Inoue et al. (31) demonstrated larger LA vol-
umes and lower LA longitudinal strain on tissue-
tracking CMR (reflecting more impaired LA reservoir
function) among patients with AF and history of
stroke or transient ischemic attack. LA reservoir
function was independently associated with stroke
(odds ratio: 0.91; p ¼ 0.018) and had incremental
diagnostic value over CHA2DS2VASc score and LA
volume. In addition, the extent of LA fibrosis on LGE-
CMR has been associated with the presence of spon-
taneous echo contrast and LAA thrombus (32).
Patients with AF and extensive LA fibrosis (>20%)
were more likely to show spontaneous echo contrast
(odds ratio: 2.6; p ¼ 0.06) and LAA thrombus (odds
ratio: 4.6; p ¼ 0.02). Daccarett et al. (33) demon-
strated the independent association between LA
fibrosis and stroke in 387 AF patients. Patients with
history of stroke (n ¼ 36, 9.3%) showed significantly
more LA fibrosis as compared with patients without
stroke (24.4  12.4% vs. 16.2  9.9%, respectively; p <
0.001). The addition of LA fibrosis extent to a model
including the clinical predictors of stroke (congestive
heart failure, age >75 years, diabetes mellitus, and
hypertension) improved the predictive statistics
(shifting the area under the curve from 0.58 to 0.72).
These structural and functional LA changes
may lead to reduced LA flow dynamics and blood
stagnation. Four-dimensional (4D) flow CMR permits
assessment of blood flow patterns over time in the LA
(Figure 5) (34). With this imaging technique, it has
been shown that patients with AF exhibit 8% to 26%
reduction in mean, median, and peak LA flow veloc-
ities as compared with age-matched controls (34).
However, the incremental predictive value of LA flow
velocities measured with 4D flow CMR over current
risk score models has not been evaluated.
Future studies prospectively evaluating the pre-
dictive value of LA and LAA imaging-based variables
for stroke in AF patients will establish the role of
these parameters to identify the patients who will
benefit from anticoagulation therapy.
LAA ANATOMY AND FUNCTION:
IMPLICATIONS FOR STROKE AND THERAPY
The LAA is a finger- or stump-like extension of the LA
with lobes that may harbor up to 90% of thrombi that
occur in patients with AF (35). In contrast to the
smooth-walled LA, the LAA contains pectinate mus-
cles that form a complex network of muscular ridges.
The transition between the rough endocardium of
the LAA to the smooth-walled LA is demarcated by
the ostium of the LAA, well defined posteriorly by the
ridge that separates the superior left pulmonary vein.The shape of the LAA is largely variable and can be
classified based on the shape and number of lobes
(Figure 6) (36). Important anatomic relationships
of the LAA to take into account when planning
transcatheter closure and radiofrequency ablation of
this structure include the superior left pulmonary
vein, the mitral valve, and the circumflex coronary
artery (Figure 7) (37). The LAA also has important
mechanical and endocrinological functions (38): the
LAA has contractile properties, and its distensibility is
larger than the LA, contributing to LA pressure
modulation (39). In addition, the concentration of
atrial natriuretic peptide is largest in the LAA (40).
Through activation of stretch-sensitive receptors
and the effects of the atrial natriuretic peptide on
heart rate, diuresis, and natriuresis, the LAA helps to
modulate the LA pressure (38).
The LAA is also an important source of AF (41).
Of 987 patients undergoing radiofrequency catheter
ablation, 27% showed firing from the LAA, whereas in
8.7%, the LAA was the only source of arrhythmia.
The BELIEF (Effect of Empirical Left Atrial Appendage
Isolation on Long-Term Procedure Outcome in Pa-
tients With Longstanding Persistent Atrial Fibrillation
Undergoing Catheter Ablation) study showed that the
addition of electrical LAA isolation to extensive
ablation of the LA resulted in lower rates of AF
recurrence at 12-month follow-up, as compared with
extensive ablation of the LA alone (44% vs. 72%) (42).
Echocardiography is the imaging technique of
first choice to evaluate the LAA. Particularly, trans-
esophageal echocardiography (TEE) permits accurate
assessment of the LAA anatomy and is the reference
standard to diagnose thrombus (sensitivity 100%
and specificity 99%) (43). The presence of dense
spontaneous echo contrast and large dimensions of
the LAA (>34 cm3) have been associated with
increased risk of stroke (28,44,45). The use of ultra-
sound contrast agents during TEE improve the diag-
nostic accuracy for LAA thrombus and reduces the
number of uncertain results from 17.8% to 5.6% (46).
The function of the LAA is most commonly assessed
with pulsed-wave Doppler tracing of the LAA flow. In
AF, the LAA flow pattern is characterized by saw
tooth signals of variable amplitude (Figure 8). LAA
systolic velocities <20 cm/s have been associated
with spontaneous echo contrast and risk of
stroke (47).
3D imaging techniques such as 3D TEE, CMR,
and CT provide accurate measurements of the LAA
appendage size, visualization of LAA thrombus,
and assessment of the anatomic spatial relationships
to be considered for transcatheter LAA closure.
3D TEE is key during the planning and guidance of
FIGURE 5 4D CMR to Assess LA Flow
4D flow MRI data & 3D LA segmentation
LA volume = 107ml
CHA2DS2-VASc = 1






































Examples of 2 patients with atrial fibrillation, comparable LA volumes, and low CHA2DS2VASc scores, but different LA flow patterns based on
4-dimensional (4D) CMR. Reproduced with permission from Lee et al. (34). CHA2DS2-VASc ¼ congestive heart failure, hypertension, age $75
years, diabetes mellitus, prior stroke, transient ischemic attack, or thromboembolism, vascular disease, age 65-74 years, sex category
(female); LV ¼ left ventricle; MRI ¼ magnetic resonance imaging; other abbreviations as in Figures 1 and 2.
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3164transcatheter LAA closure. By aligning the multi-
planar reformation planes, the dimensions of the
ostium and the landing zone where the closure
device will be deployed can be measured (Figure 9).
However, the morphology of the LAA is better
visualized with multidetector row CT. A recent
meta-analysis including 8 studies and 2,596 patients
with AF (84% with CHADS2 score) showed that
chicken wing LAA morphology was associated withlower risk of thromboembolic event as compared with
other morphologies (odds ratio: 0.46; 95% confidence
interval: 0.36 to 0.58) (48). For detection of LAA
thrombus, multidetector row CT data should be
acquired with specific protocols that ensure full
replenishment of the LAA by iodinated contrast
(49–51). Furthermore, CT provides comprehensive
information for selection of LAA closure device in AF
patients with relative or absolute contraindications
FIGURE 6 Morphology of the LAA
The classification of the left atrial appendage (LAA) morphology is based on the shape of the central and secondary lobes: windsock (A) (with 1 central lobe),
chicken wing (B) (with a central lobe bended), cauliflower (C) (when the central lobe is short and with several lobes leading to a distal width larger than
the proximal part), and cactus (D) (with a central lobe leading to several secondary lobes superior and inferiorly).
FIGURE 7 Anatomic Relationships of the LAA to Consider in Transcatheter Closure Procedures
Example of a patient receiving an AMULET device closure (A and B). Note the anterior position of the circumflex coronary artery (Cx) relative
to the left atrial appendage (LAA) at baseline (A). After insertion of the device, the Cx is patent, and the flow of the left superior pulmonary
vein (LSPV) is not compromised (B). In C and D, an example of a patient receiving a WATCHMAN device is shown. The anterior spatial
relationship of the Cx and the LAA (asterisk) can be analyzed with computed tomography (C). Note the close proximity of the deployed
device to the Cx (black arrow) (D). Reprinted with permission from Ismail et al. (37).
J A C C V O L . 7 0 , N O . 2 5 , 2 0 1 7 Delgado et al.
D E C E M B E R 2 6 , 2 0 1 7 : 3 1 5 7 – 7 2 LA and LAA: Implications for AF and Stroke
3165




















(A) A schematic pulsed-wave Doppler recording of the left atrial appendage (LAA) flow velocities across the cardiac cycle (electrocardiogram). (B) The pulsed-wave
Doppler recording of a patient in sinus rhythm is displayed. Note that the numbers correspond to the wave reflections during LAA contraction, LAA filling, late
systolic reflections, and early diastolic LAA outflow as in the schematic representation of A. During atrial fibrillation, the pulsed-wave Doppler pattern of the LAA flow
resembles a saw tooth (C).
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3166for oral anticoagulation. Currently available devices
differ in size, shape, and methodology of deploy-
ment: whereas the Amplatzer AMULET (St. Jude
Medical, Plymouth, Massachusetts) consists of a
self-expandable nitinol distal lobe anchored in the
neck of the LAA and a proximal disc that enhances
the complete closure of the ostium, the WATCHMAN
device (Boston Scientific, Natick, Massachusetts) is a
nitinol cage with 10 peripheral anchors and a fabricFIGURE 9 Assessment of LAA Dimensions and Evaluation of Throm
(A) The multiplanar reformation planes from 3-dimensional transesophag
obtain the cross-sectional view of the left atrial appendage (LAA) ostium
for transcatheter closure of the LAA (B, arrow).cap that is anchored in the ostium of the LAA.
The LARIAT device (SentreHEART, Redwood City,
California), by contrast, is a combined endocardial
and epicardial method to exclude the LAA.
The anatomic prerequisites for each device are
well defined by the manufacturers (Figure 10). The
evidence from a limited number of randomized trials
has demonstrated that transcatheter LAA closure
is noninferior to warfarin in AF patients (52).bus Before Transcatheter Closure
eal echocardiography volume acquisition. The planes are aligned to
. The presence of large thrombus is a contraindication
FIGURE 10 Requirements for Transcatheter LAA Closure
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Anatomic characteristics of the left atrial appendage (LAA) for each closure device are summarized. CT ¼ computed tomography.
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3167However, there remain several safety and patient
selection concerns that will be addressed in on-going
post-marketing surveillance registries and random-
ized trials (52).
INFLUENCE OF THE LV ON LA REMODELING
ASSOCIATED WITH AF
Changes in LV function, structure, and tissue
characteristics have also been associated with LA
remodeling and AF. However, some uncertainty
remains as to the extent to which they are a cause or
a consequence of AF (53). CMR techniques have
provided new insights into the association of LA
remodeling and LV changes in AF. Assessment of
diffuse LV myocardial fibrosis with CMR T1-mapping
with or without gadolinium-based contrast agents
has been applied in patients with AF. Measurement of
post-contrast myocardial T1 time allows for accurate
measurement of changes in extracellular volume
associated with edema or interstitial fibrosis. AF has
been associated with higher native (pre-contrast)
T1 values (54), lower LV post-contrast T1 values (55),
and elevated extracellular volume (56), which are all
consistent with the presence of diffuse LV fibrosis.
Most importantly, lower LV post-contrast T1 valueshave been associated with recurrence of AF after
catheter ablation, independent of age and LV systolic
dysfunction (55–57). The association between
increased LV diffuse fibrosis and LA remodeling was
demonstrated by Beinart et al. (58) in 51 patients with
AF. Compared with healthy volunteers, AF patients
had lower LA and LV post-contrast T1 relaxation
times (387 [interquartile range (IQR): 364 to 428] ms
vs. 459 [IQR: 418 to 532] ms; p < 0.001, and 491 [IQR:
460 to 527] ms vs. 529 [IQR: 496 to 543] ms;
p ¼ 0.074), respectively. Increasing values of LV post-
contrast T1 time correlated modestly with increasing
values of LA post-contrast T1 time (Spearman rho
correlation coefficient ¼ 0.41; p < 0.001), suggesting
that myocardial fibrosis affects both the LA and the
LV. However, it may be difficult to demonstrate
whether LV fibrosis precedes LA fibrosis or vice versa.
In addition, using an index of LV myocardial
diffuse fibrosis derived from CMR post-contrast T1
times of the LV, the PRIMERI (Personalized Risk
Identification and Management for Arrhythmias and
Heart Failure by ECG and CMR) study showed
that increasing LV myocardial diffuse fibrosis was
associated with electrocardiographic indices of
prolonged interatrial conduction in 91 patients in
sinus rhythm after adjustment for body mass index,
FIGURE 11 Representative 31P-MRS Spectra and Derived PCr/ATP Ratios From the Mid-Ventricular Septum
A
AF Patient Pre-Ablation PCr/ATP = 1.74





[IQR 1.5% - 100%]
AF Burden
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The 31P-MRS spectra and derived PCr/ATP ratios are shown in a matched control subject (A, top panel) and an AF patient pre-ablation
(A, bottom panel). Despite a significant reduction in AF burden at a median of 7 months after catheter ablation (p < 0.001) (B), there was no
change in PCr/ATP ratio in AF patients after ablation (p ¼ 0.57) (C, left panel), with myocardial energetics remaining significantly impaired
compared with matched control subjects in sinus rhythm (p ¼ 0.001) (C, right panel). Adapted from Wijesurendra et al. (53). 2,3-DPG ¼ 2,3-
diphosphoglycerate; 31P-MRS ¼ 31P-magnetic resonance spectroscopy; AF ¼ atrial fibrillation; IQR ¼ interquartile range; PCr/ATP ¼ creatine
phosphate/adenosine triphosphate; PDE ¼ phosphodiester.
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Assessment of LV strain with speckle tracking echo-
cardiography permits identification of AF patients
with increased LV fibrosis despite showing preserved
LV ejection fraction. In 53 AF patients undergoingradiofrequency catheter ablation, patients who
remained in sinus rhythm at follow-up showed better
LV longitudinal strain compared with patients who
experienced AF recurrences (19.6  2.6% vs. 17.9 
1.8%; p < 0.005), whereas no differences were
CENTRAL ILLUSTRATION Association Between LA Remodeling, AF, and Stroke
Delgado, V. et al. J Am Coll Cardiol. 2017;70(25):3157–72.
Left atrial (LA) and left atrial appendage (LAA) remodeling are common to the pathophysiology of atrial fibrillation (AF) and stroke. Increased LA volume, increased LA
fibrosis, and impaired LA function are the main hallmarks of LA remodeling. Although an increase in LA volume can be assessed with any imaging modality (preferably
with 3-dimensional techniques), increased LA fibrosis is evaluated with cardiovascular magnetic resonance (CMR) techniques (arrows), and LA function is better
assessed with imaging techniques that directly evaluate the myocardial deformation (e.g., speckle tracking echocardiography). Specific imaging parameters related
to AF include LA conduction delay, assessed with echocardiographic tissue Doppler imaging (PA-TDI) and increased LA adipose tissue evaluated with computed
tomography (CT). Imaging parameters indicating the risk of stroke include blood flow, blood stagnation, and thrombus formation, assessed with transesophageal
echocardiography or 4-dimensional flow CMR, and the morphology of the LAA, better assessed with CT. Evaluation of the LA remodeling process underlying
the increased risk of atrial fibrillation and stroke should also integrate the influence of the left ventricle (LV), including assessment of LV fibrosis, LV function
(strain imaging), microvascular dysfunction (nuclear imaging), and myocardial energetics with magnetic resonance spectroscopy. [¼ increased;Y ¼ reduced.
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3169observed in LV ejection fraction (59  7% vs. 61  6%;
p < 0.005) (60). These findings suggest that changes
in atrial tissue characteristics are (partially) the
consequence of a global cardiomyopathic process,
which plays an important role in promoting the new
onset and maintenance of AF, as well as its recurrence
after ablation.Furthermore, LV microvascular dysfunction and
altered myocardial energetics may also contribute to
the substrate subtending LA remodeling and AF.
Patients with AF without obstructive epicardial
coronary artery disease have been reported to have
significantly reduced LV blood flow measured with
H215O-positron emission tomography at rest and in
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3170response to adenosine (61). Evidence of LV coronary
microvascular dysfunction has also been reported
with other techniques in patients with AF (62,63) and
in animal models after AF induction (64). Similarly, a
reduction in LA perfusion in the presence of AF
or following AF induction has been found both
in experimental (65,66) and clinical studies (67).
Whether coronary microvascular dysfunction has an
impact on atrial fibrosis, myocardial energetic status,
and cardiac function remains to be established.
Nevertheless, LV energetics status evaluated by the
phosphocreatine to ATP ratio using 31phosphorous
magnetic resonance spectroscopy is significantly
impaired in patients with symptomatic “lone” AF
compared with matched control in sinus rhythm and
unchanged 7 to 9 months after AF ablation, despite
a significant reduction in AF burden and mild
improvement in LV ejection fraction (Figure 11) (53).
Future studies will need to ascertain the relationship
between impaired LV perfusion and energetics on
atrial structural and electrophysiological parameters
and AF recurrence post-ablation.
CONCLUSIONS
Significant evidence indicates that assessment of
LA and LAA anatomy and function has important
prognostic implications in new onset and perpetua-
tion of AF and risk of stroke. Selection of patients for
anticoagulation treatment or AF ablation does notroutinely include imaging-based parameters that
characterize the LA substrate. Anticoagulation ther-
apies are very efficacious in reducing the risk of
stroke of AF patients, and LA imaging may not further
improve this efficacy in patients at high risk of stroke.
Conversely, in patients with low risk of stroke, LA and
LAA imaging may further refine the risk and identify
patients who may benefit from anticoagulation
(enabling “precision medicine”). Importantly, in pa-
tients with contraindications for anticoagulation who
are referred for transcatheter closure of the LAA, CT
and echocardiography play a central role. When
selecting patients with AF who may benefit from
catheter ablation techniques, imaging techniques to
evaluate LA size, function, and myocardial fibrosis
have shown to be important. The ongoing DECAAF-II
(Efficacy of DE-MRI-Guided Ablation vs. Conven-
tional Catheter Ablation of Atrial Fibrillation II) trial
will help to establish the role of LGE CMR to guide
ablation procedures and improve the efficacy of the
ablation technique. Finally, to understand the LA
remodeling process, LV structural and functional
changes need to be considered because they are
closely interrelated (Central Illustration).
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